01 January 2019 → 31 December 2025
Regional and community funding: Special Research Fund
Medical and health sciences
- Respiratory medicine
Asthma Chronic Obstructive Pulmonary Disease (COPD) RNA-biomarkers RNA-therapeutics airway epithelial cells
Through multidisciplinary collaboration within this interfaculty RNA-MAGIC consortium, we will discover novel prognostic and theragnostic RNA-based biomarkers in asthma and COPD. By combining transcriptional profiling of airway epithelial cells with CRISPR-interference and drug repurposing investigations, the consortium will identify novel therapeutic targets in asthma and COPD, validate these in vivo using translational approaches, and optimize RNA-based drug delivery via inhalation.